HM Payson & Co’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150K Hold
1,000
﹤0.01% 501
2026
Q1
$92.4K Hold
1,000
﹤0.01% 573
2025
Q4
$102K Hold
1,000
﹤0.01% 548
2025
Q3
$62.5K Hold
1,000
﹤0.01% 639
2025
Q2
$52K Hold
1,000
﹤0.01% 644
2025
Q1
$42.6K Hold
1,000
﹤0.01% 672
2024
Q4
$30.6K Hold
1,000
﹤0.01% 712
2024
Q3
$22.9K Hold
1,000
﹤0.01% 751
2024
Q2
$28.9K Hold
1,000
﹤0.01% 694
2024
Q1
$20.6K Hold
1,000
﹤0.01% 744
2023
Q4
$27.1K Hold
1,000
﹤0.01% 690
2023
Q3
$29.6K Hold
1,000
﹤0.01% 673
2023
Q2
$35.8K Hold
1,000
﹤0.01% 640
2023
Q1
$23.4K Hold
1,000
﹤0.01% 691
2022
Q4
$27.2K Hold
1,000
﹤0.01% 641
2022
Q3
$54K Hold
1,000
﹤0.01% 560
2022
Q2
$40K Hold
1,000
﹤0.01% 617
2022
Q1
$66K Buy
1,000
+500
+100% +$34.2K ﹤0.01% 555
2021
Q4
$50K Sell
500
-16
-3% -$1.66K ﹤0.01% 608
2021
Q3
$65K Hold
516
﹤0.01% 550
2021
Q2
$64K Hold
516
﹤0.01% 546
2021
Q1
$79K Hold
516
﹤0.01% 523
2020
Q4
$67K Buy
516
+16
+3% +$1.84K ﹤0.01% 550
2020
Q3
$56K Hold
500
﹤0.01% 541
2020
Q2
$41K Hold
500
﹤0.01% 553
2020
Q1
$35K Hold
500
﹤0.01% 545
2019
Q4
$39K Hold
500
﹤0.01% 623
2019
Q3
$32K Hold
500
﹤0.01% 657
2019
Q2
$43K Buy
+500
New +$38.2K ﹤0.01% 624

Other funds holding GH

HM Payson & Co's GH Position: Q2 2026 in Review

HM Payson & Co held its Guardant Health (GH) position steady in Q2 2026 at 1,000 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

HM Payson & Co first reported a position in GH in Q2 2019 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • HM Payson & Co held 1,000 shares of Guardant Health worth $150K as of Q2 2026.
  • HM Payson & Co left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #501 holding.
  • HM Payson & Co first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.